Agomelatine dominant for MDD in Turkey . . .

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.656, 2012-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Agomelatine fits the bill for MDD in Ireland, Hungary and Poland

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 617, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Escitalopram proves dominant over sertraline in MDD

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 525, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Agomelatine in depression

By Smeraldi Enrico Delmonte Dario

Expert Opinion on Drug Safety, Vol. 12, Iss. 6, 2013-11 ,pp. : 873-880

Informa Healthcare

Access to resources Recommend Favorite

Escitalopram ahead of the rest in MDD

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 481, 2005-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Escitalopram ahead of the game in MDD

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 479, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite